CAIHL read · Jun 9, 2026

← Back to Jun 9, 2026 scan

Ilant's AI-powered obesity care model raises $15m

What CAIHL does

Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.

The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.

This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.

How this item reads through CAIHL

Primary user

patient

Patients, families, and care partners are the primary users of this AI.

Hosting

public

Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.

Interests

commercial

Prioritizes vendor or platform commercial interests (advertising, data, retention).

Agency

constraining

Channels patients toward predetermined pathways or substitutes for patient capabilities.

One-sentence synthesis

AI-mediated obesity-care funnel anchored on GLP-1; constraining patient agency because the model's objective is medication adherence.

How this item appeared in the daily scan

Editor's note: Obesity care is the AI vertical with the strongest commercial gravity right now because the drug is the product the AI is funneling into. The patient who walks into Ilant is being routed inside a model whose primary objective is GLP-1 adherence.

Summary: Longevity.Technology: Ilant raises $15M Series A for an AI-powered obesity-care model — clinical decision support layered onto GLP-1 prescribing and lifestyle protocol management.

Read the original source →

methodology

Limitations

CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.